Skip to main content
U.K. Edition
Friday, 25 June 2021

Moderna COVID-19 vaccine

RNA COVID-19 vaccine

Moderna COVID-19 vaccine
Moderna COVID-19 vaccine

The Moderna COVID‑19 vaccine, codenamed mRNA-1273, is a COVID-19 vaccine developed by Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA). It is used in people aged 18 years and older to provide protection against infection by the SARS-CoV-2 virus, which causes COVID-19. It is designed to be administered as two 0.5 mL doses given by intramuscular injection at an interval of four weeks apart.

0 shares 1 views

News coverage

Moderna COVID-19 vaccine media coverage


More coverage